Skip to content

Testing the effect of ayurvedic kashaya as oral medicine and enema therapy in patients with kidney disease related to with diabetes.

Effect of Gokshuradi kashaya pana and Gokshuradi ruksha vasti in Diabetic Nephropathy - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/092024
Enrollment
23
Registered
2025-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)

Interventions

None listed

Sponsors

Dr Haripriya Vijayan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed subjects of type 2 Diabetes Mellitus with Diabetic nephropathy With age group between 35-70 yrs With microalbumin ranges between 20 -200 microgram/min S.Creatinine level within 5 Who are fit for Vasthikarma Who are willing to participate and able to give consent

Exclusion criteria

Exclusion criteria: HbA1C greater than 9 Diabetic Nephropathy Stage 4 and 5 Pregnancy and lactation Known case of uncontrolled other systemic illness With persistent UTI Taking ACE inhibitors and ARBs Subjects with other severe debilitating diseases

Design outcomes

Primary

MeasureTime frame
Changes in Albumin Creatinine ratioTimepoint: 0th and 31st day

Secondary

MeasureTime frame
Changes in eGFRTimepoint: 0th and 30th day

Countries

India

Contacts

Public ContactDr Sunil John Thykkattil MD Ayu

Govt Ayurveda College Tripunithura Ernakulam

drsuniljohn@gmail.com9447500822

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026